Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014.

Kirson NY, Meadows ES, Desai U, Smith BP, Cheung HC, Zuckerman P, Matthews BR.

J Am Geriatr Soc. 2019 Dec 3. doi: 10.1111/jgs.16262. [Epub ahead of print]

PMID:
31797361
2.

Reduced medical spending associated with increased use of a remote diabetes management program and lower mean blood glucose values.

Whaley CM, Bollyky JB, Lu W, Painter S, Schneider J, Zhao Z, He X, Johnson J, Meadows ES.

J Med Econ. 2019 Sep;22(9):869-877. doi: 10.1080/13696998.2019.1609483. Epub 2019 May 8.

PMID:
31012392
3.

Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study.

Kariburyo F, Wang Y, Cheng IE, Wang L, Morgenstern D, Xie L, Meadows E, Danella J, Cher ML.

BMC Urol. 2018 Jun 4;18(1):55. doi: 10.1186/s12894-018-0372-1.

4.

Why We Need a Formal Systematic Approach to Validating Psychological Tests: The Case of the Rorschach Comprehensive System.

Mihura JL, Bombel G, Dumitrascu N, Roy M, Meadows EA.

J Pers Assess. 2019 Jul-Aug;101(4):374-392. doi: 10.1080/00223891.2018.1458315. Epub 2018 May 3.

PMID:
29723065
5.

Healthcare costs among men with favorable risk prostate cancer managed with observation strategies versus immediate treatment in an integrated healthcare system.

Kariburyo F, Wang Y, Cheng IE, Wang L, Morgenstern D, Asner I, Xie L, Meadows E, Danella J.

J Med Econ. 2017 Aug;20(8):825-831. doi: 10.1080/13696998.2017.1333512. Epub 2017 Jun 8.

PMID:
28534659
6.

Rejection Sensitivity as a Moderator of Psychosocial Outcomes Following Pediatric Traumatic Brain Injury.

Meadows EA, Owen Yeates K, Rubin KH, Taylor HG, Bigler ED, Dennis M, Gerhardt CA, Vannatta K, Stancin T, Hoskinson KR.

J Int Neuropsychol Soc. 2017 Jul;23(6):451-459. doi: 10.1017/S1355617717000352. Epub 2017 May 17.

7.

The use of vignettes to empower effective responses to attempted sexual assault.

Allen KT, Meadows EA.

J Am Coll Health. 2017 May-Jun;65(4):250-258. doi: 10.1080/07448481.2016.1278376. Epub 2017 Jan 6.

PMID:
28060583
8.

A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.

Mendell JR, Sahenk Z, Malik V, Gomez AM, Flanigan KM, Lowes LP, Alfano LN, Berry K, Meadows E, Lewis S, Braun L, Shontz K, Rouhana M, Clark KR, Rosales XQ, Al-Zaidy S, Govoni A, Rodino-Klapac LR, Hogan MJ, Kaspar BK.

Mol Ther. 2015 Jan;23(1):192-201. doi: 10.1038/mt.2014.200. Epub 2014 Oct 17.

9.

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.

Meadows ES, Bae JP, Zagar A, Sugihara T, Ramaswamy K, McCracken R, Heiselman D.

BMC Res Notes. 2012 Jul 2;5:342. doi: 10.1186/1756-0500-5-342.

10.

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

Meadows ES, Mitchell BD, Bolge SC, Johnston JA, Col NF.

BMC Womens Health. 2012 Jan 6;12:1. doi: 10.1186/1472-6874-12-1.

11.

The impact of teriparatide adherence and persistence on fracture outcomes.

Yu S, Burge RT, Foster SA, Gelwicks S, Meadows ES.

Osteoporos Int. 2012 Mar;23(3):1103-13. doi: 10.1007/s00198-011-1843-3. Epub 2011 Dec 8.

PMID:
22159748
12.

Persistence with biologic therapies in the Medicare coverage gap.

Tamariz L, Uribe CL, Luo J, Hanna JW, Ball DE, Krohn K, Meadows ES.

Am J Manag Care. 2011 Nov;17(11):753-9.

13.

Cost-effectiveness of prasugrel in a US managed care population.

Mauskopf JA, Graham JB, Bae JP, Ramaswamy K, Zagar AJ, Magnuson EA, Cohen DJ, Meadows ES.

J Med Econ. 2012;15(1):166-74. doi: 10.3111/13696998.2011.637590. Epub 2011 Nov 18.

PMID:
22066985
14.

Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study.

Gold DT, Weinstein DL, Pohl G, Krohn KD, Chen Y, Meadows ES.

J Osteoporos. 2011;2011:314970. doi: 10.4061/2011/314970. Epub 2011 Oct 13.

15.

Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.

Conwell LJ, Esposito D, Garavaglia S, Meadows ES, Colby M, Herrera V, Goldfarb S, Ball D, Marciniak M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

PMID:
21616722
16.

Compliance with mammography and bone mineral density screening in women at least 50 years old.

Meadows ES, Whangbo A, McQuarrie N, Gilra N, Mitchell BD, Mershon JL.

Menopause. 2011 Jul;18(7):794-801. doi: 10.1097/gme.0b013e3182083f28.

PMID:
21505373
17.

Myogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice.

Meadows E, Flynn JM, Klein WH.

PLoS One. 2011 Jan 14;6(1):e16184. doi: 10.1371/journal.pone.0016184.

18.

Myogenin regulates exercise capacity and skeletal muscle metabolism in the adult mouse.

Flynn JM, Meadows E, Fiorotto M, Klein WH.

PLoS One. 2010 Oct 22;5(10):e13535. doi: 10.1371/journal.pone.0013535.

19.

Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases.

Moresi V, Williams AH, Meadows E, Flynn JM, Potthoff MJ, McAnally J, Shelton JM, Backs J, Klein WH, Richardson JA, Bassel-Duby R, Olson EN.

Cell. 2010 Oct 1;143(1):35-45. doi: 10.1016/j.cell.2010.09.004.

20.

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance.

Foster SA, Foley KA, Meadows ES, Johnston JA, Wang SS, Pohl GM, Long SR.

Osteoporos Int. 2011 Feb;22(2):551-7. doi: 10.1007/s00198-010-1297-z. Epub 2010 Aug 27.

PMID:
20798929
21.

Pattern of clopidogrel use in hospitalized patients receiving percutaneous coronary interventions.

Dean BB, Yu HT, Bae JP, Fiske S, Meadows E, Xiong Y, Emons MF.

Am J Health Syst Pharm. 2010 Sep 1;67(17):1430-7. doi: 10.2146/ajhp100008.

PMID:
20720242
22.

Illness-associated productivity costs among women with employer-sponsored insurance and newly diagnosed breast cancer.

Meadows ES, Johnston SS, Cao Z, Foley KA, Pohl GM, Johnston JA, Ramsey SD.

J Occup Environ Med. 2010 Apr;52(4):415-20. doi: 10.1097/JOM.0b013e3181d65db7.

PMID:
20357681
23.

A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression.

Tang H, Macpherson P, Marvin M, Meadows E, Klein WH, Yang XJ, Goldman D.

Mol Biol Cell. 2009 Feb;20(4):1120-31. doi: 10.1091/mbc.E08-07-0759. Epub 2008 Dec 24.

24.

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.

Foster SA, Foley KA, Meadows ES, Johnston JA, Wang S, Pohl GM, Long SR.

BMC Womens Health. 2008 Dec 23;8:24. doi: 10.1186/1472-6874-8-24.

25.

Myogenin regulates a distinct genetic program in adult muscle stem cells.

Meadows E, Cho JH, Flynn JM, Klein WH.

Dev Biol. 2008 Oct 15;322(2):406-14. doi: 10.1016/j.ydbio.2008.07.024. Epub 2008 Jul 30.

26.

Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance.

Meadows ES, Rousculp M, Sasser AC, Birnbaum HG, Moyneur E, Mallet D, Johnston JA.

Curr Med Res Opin. 2007 Dec;23(12):3215-22.

PMID:
18021497
27.

Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.

Davie JK, Cho JH, Meadows E, Flynn JM, Knapp JR, Klein WH.

Dev Biol. 2007 Nov 15;311(2):650-64. Epub 2007 Aug 16.

28.

Assessment of the clinical management of fragility fractures and implications for the new HEDIS osteoporosis measure.

Foley KA, Foster SA, Meadows ES, Baser O, Long SR.

Med Care. 2007 Sep;45(9):902-6.

PMID:
17712262
29.

Characteristics of patients initiating teriparatide for the treatment of osteoporosis.

Foster SA, Foley KA, Meadows ES, Johnston JA, Wang S, Pohl GM, Long SR.

Osteoporos Int. 2008 Mar;19(3):373-7. Epub 2007 Aug 21.

PMID:
17710352
30.

Smooth muscle persists in the muscularis externa of developing and adult mouse esophagus.

Rishniw M, Fisher PW, Doran RM, Meadows E, Klein WH, Kotlikoff MI.

J Muscle Res Cell Motil. 2007;28(2-3):153-65. Epub 2007 Jul 19.

PMID:
17638088
31.

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia.

Meadows ES, Klein R, Rousculp MD, Smolen L, Ohsfeldt RL, Johnston JA.

BMC Womens Health. 2007 Apr 17;7:6.

32.

Economic burden of osteoporosis-related fractures in Medicaid.

Rousculp MD, Long SR, Wang S, Schoenfeld MJ, Meadows ES.

Value Health. 2007 Mar-Apr;10(2):144-52.

33.

Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies.

Meadows ES, Stock J, Johnston JA.

Med Decis Making. 2006 Nov-Dec;26(6):633-5; author reply 636-7. No abstract available.

PMID:
17099202
34.

Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).

Weinstein DL, Cohen JS, Liu C, Meadows ES, Plouffe L Jr, Muram D; DESIRE Study Group.

Curr Med Res Opin. 2006 Nov;22(11):2121-9.

PMID:
17076972
35.

Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size.

Knapp JR, Davie JK, Myer A, Meadows E, Olson EN, Klein WH.

Development. 2006 Feb;133(4):601-10. Epub 2006 Jan 11.

36.

Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinence.

Bent AE, Gousse AE, Hendrix SL, Klutke CG, Monga AK, Yuen CK, Meadows ES, Yalcin I, Muram D; Duloxetine Mixed Urinary Incontinence Study Group.

Obstet Gynecol. 2005 Oct;106(4):767-73.

PMID:
16199634
37.

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.

Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN.

Cell. 2004 Nov 12;119(4):555-66.

39.

Rationale for a non-inferiority clinical trial design focused on subpopulations.

Kulkarni PM, Meadows ES, Ahuja S, Muram D, Plouffe L Jr.

Curr Med Res Opin. 2004 Oct;20(10):1641-7.

PMID:
15462697
40.

Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, McKinsey TA.

Mol Cell Biol. 2004 Oct;24(19):8374-85.

41.

Crystal structure of the priming beta-ketosynthase from the R1128 polyketide biosynthetic pathway.

Pan H, Tsai Sc, Meadows ES, Miercke LJ, Keatinge-Clay AT, O'Connell J, Khosla C, Stroud RM.

Structure. 2002 Nov;10(11):1559-68.

42.

In vitro reconstitution and analysis of the chain initiating enzymes of the R1128 polyketide synthase.

Meadows ES, Khosla C.

Biochemistry. 2001 Dec 11;40(49):14855-61.

PMID:
11732905
43.

Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey.

Lamontagne S, Meadows E, Luk P, Normandin D, Muise E, Boulet L, Pon DJ, Robichaud A, Robertson GS, Metters KM, Nantel F.

Brain Res. 2001 Nov 30;920(1-2):84-96.

PMID:
11716814
44.

Alkali metal cation-pi interactions observed by using a lariat ether model system.

Meadows ES, De Wall SL, Barbour LJ, Gokel GW.

J Am Chem Soc. 2001 Apr 4;123(13):3092-107.

PMID:
11457020
45.

Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D-homosteroid analogues of the anesthetic steroids (3alpha, 5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20-one.

Covey DF, Han M, Kumar AS, de La Cruz MA, Meadows ES, Hu Y, Tonnies A, Nathan D, Coleman M, Benz A, Evers AS, Zorumski CF, Mennerick S.

J Med Chem. 2000 Aug 24;43(17):3201-4. No abstract available.

PMID:
10966737
46.

Synthetic receptors as models for alkali metal cation-pi binding sites in proteins.

De Wall SL, Meadows ES, Barbour LJ, Gokel GW.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6271-6.

47.

Urinary incontinence in a geriatric patient with a complex neurologic history.

Wells JA, Ouslander JG, Meadows E, Johnson VY.

J Wound Ostomy Continence Nurs. 1999 Sep;26(5):270-4; discussion 274-5. No abstract available.

PMID:
10795211
48.

Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly.

Nantel F, Meadows E, Denis D, Connolly B, Metters KM, Giaid A.

FEBS Lett. 1999 Sep 3;457(3):475-7.

49.

Treatments for patients with pelvic pain.

Meadows E.

Urol Nurs. 1999 Mar;19(1):33-5. Review.

PMID:
10373990
50.

A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims.

Foa EB, Dancu CV, Hembree EA, Jaycox LH, Meadows EA, Street GP.

J Consult Clin Psychol. 1999 Apr;67(2):194-200.

PMID:
10224729

Supplemental Content

Loading ...
Support Center